The Journal of Practical Medicine >
EBV infection and influencing factors of nasopharyngeal carcinoma screening population in Guangzhou
Received date: 2023-09-04
Online published: 2024-05-21
Objective To study EBV infection in nasopharyngeal carcinoma screening population in Guangzhou and analyze the influencing factors. Methods The data of individuals (aged 20 years and above) having EBV antibody of VCA-IgA and NA1-IgA test in Guangzhou Cadre and Talent Health Management Centerwere collected. Current status of EBV infection was studied and its influencing factors were analyzed by logistic regression analysis. Results A total of 55 311 subjects were screened, including 35 429 males (64.05%) and 19,882 females (35.95%).The overall EBV infection rate was 8.00%. There was no significant differences in the infection rate between different sex groups(P > 0.05). The infection rate of EBV increased with age, with infection rate of 7.07% in individuals aged 20 ~ 39 years, 7.86% in those aged 40 ~ 59 years,10.11 % in those of 60 ~ 79 years old, and 10.99% in those aged ≥ 80 years, showing statistical significance(χ2 = 85.487,P < 0.01). Logistic regression analysis showed that EBV infection risk increased significantly with advancing age. The odds of EBV infection in individuals aged 40 ~ 59 years were 10.6% higher compared to those aged 20 ~ 39 years (OR = 1.106, 95% CI: 1.028 ~ 1.190). The odds of EBV infection in individuals aged 60 ~ 79 years were 42.2% higher compared to those aged 20 ~ 39 years (OR = 1.422, 95% CI: 1.288 ~ 1.569). Furthermore, the odds of EBV infection in individuals aged ≥ 80 years were 53.1% higher compared to those aged 20 ~ 39 years (OR = 1.531, 95% CI: 1.230 ~ 1.906).A prior diagnosis of hypertension significantly increased the odds of EBV infection (OR = 1.105, 95%CI: 1.003 ~1.218). However, diabetes history exerted no influence on the outcome of EBV infection(P > 0.05). Conclusions The overall infection rate of EBV in Guangzhou is 8.00%. Advanced age and hypertension history are the risk factors of EBV. The screening and prevention and control of EBV susceptible people should be strengthened.
Key words: nasopharyngeal carcinoma; EB virus infection; risk factors
Qian DOU , Yuzhen ZHANG , Yong. ZHOU . EBV infection and influencing factors of nasopharyngeal carcinoma screening population in Guangzhou[J]. The Journal of Practical Medicine, 2024 , 40(10) : 1440 -1444 . DOI: 10.3969/j.issn.1006-5725.2024.10.019
| 1 | DUNMIRE S K, VERGHESE P S, BALFOUR H H J. Primary Epstein-Barr virus infection[J]. J Clin Virol, 2018,102:84-92. doi:10.1016/j.jcv.2018.03.001 |
| 2 | MCKENZIE J, EL-GUINDY A. Epstein-Barr Virus Lytic Cycle Reactivation[J]. Curr Top Microbiol Immunol, 2015,391:237-261. doi:10.1007/978-3-319-22834-1_8 |
| 3 | SATOU A, NAKAMURA S. EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency[J]. Cancer Med, 2021,10(19):6777-6785. doi:10.1002/cam4.4198 |
| 4 | KANDA T, YAJIMA M, IKUTA K. Epstein-Barr virus strain variation and cancer[J]. Cancer Sci, 2019,110(4):1132-1139. doi:10.1111/cas.13954 |
| 5 | NOWALK A, GREEN M. Epstein-Barr Virus[J]. Microbiol Spectr, 2016,4(3):151-162. doi:10.1128/microbiolspec.dmih2-0011-2015 |
| 6 | 姚磊, 王甜甜, 周爱升. 鼻咽部分泌物和外周血EBV-DNA检测在鼻咽癌分子诊断中的作用评价[J]. 临床和实验医学杂志, 2021,20(18):2005-2008. doi:10.3969/j.issn.1671-4695.2021.18.028 |
| 7 | TSAO S W, TSANG C M, LO K W. Epstein-Barr virus infection and nasopharyngeal carcinoma[J]. Philos Trans R Soc Lond B Biol Sci, 2017,372(1732):20160270. doi:10.1098/rstb.2016.0270 |
| 8 | 许风霞. 进行EB病毒抗体检测在诊断鼻咽癌方面的临床价值[J]. 中国医学文摘(耳鼻咽喉科学), 2023,38(2):49-52. |
| 9 | 曹毛毛,陈万青. 中国癌症筛查现状[J]. 科技导报, 2023,41(18):11-17. |
| 10 | 周洁瑕. 鼻咽癌为何被称为“广东癌”[J]. 家庭医药·快乐养生, 2019, 9:75. |
| 11 | 朱烨, 林意俊. 佛山市健康体检人群EB病毒抗体检测阳性结果分析[J]. 中国医药科学, 2022,12(6):135-141. doi:10.3969/j.issn.2095-0616.2022.06.035 |
| 12 | 李婧怡,马学军,申辛欣,等. EB病毒检测技术研究进展[J].病毒学报, 2022,38(6):1512-1518. |
| 13 | CUI J, YAN W, XU S, et al. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients[J]. PLoS One, 2018,13(3):e193171. doi:10.1371/journal.pone.0193171 |
| 14 | 吴文娟,王新明,许东勤,等. 鼻咽癌患者中EB病毒抗体研究概述[J]. 中国医学工程, 2023,31(9):42-46. |
| 15 | 费林瑶,侯昕,付邦军,等. EB病毒抗体检测鼻咽癌的诊断价值分析[J]. 中国医学文摘(耳鼻咽喉科学), 2023,38(4):106-108. |
| 16 | KERR J R. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors[J]. J Clin Pathol, 2019,72(10):651-658. doi:10.1136/jclinpath-2019-205822 |
| 17 | KIMURA H, ITO Y, SUZUKI R, et al. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease[J]. Rev Med Virol, 2008,18(5):305-319. doi:10.1002/rmv.582 |
| 18 | 张改玲. EB病毒抗体联合淋巴细胞亚群分析诊断传染性单核细胞增多症患儿的临床价值[J]. 吉林医学, 2023,44(11):3090-3093. doi:10.3969/j.issn.1004-0412.2023.11.026 |
| 19 | 沈子园,胡灵灵,张颢,等. EB病毒在结外NK/T细胞淋巴瘤中的预后价值:一项淮海淋巴瘤协作组的多中心回顾性研究[J]. 中国现代医学杂志, 2023,33(21):9-15. doi:10.3969/j.issn.1005-8982.2023.21.002 |
| 20 | 李萍,安莉莉,韩冰. 血清ADA、IL-10及TLR9与EBV相关传染性单核细胞增多症患儿 EBV-DNA载量的相关性[J]. 国际检验医学杂志, 2023,44(23):2924-2928. |
| 21 | 卢绍佳, 吴锡辉, 杨晓燕, 等. 血清EB NA1-IgA,VCA-IgA,VEA-IgA对鼻咽癌诊断价值的研究[J]. 实验与检验医学, 2021,39(1):142-144. |
| 22 | DASKALOGIANNI C, PYNDIAH S, APCHER S, et al. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers[J]. J Pathol, 2015,235(2):334-341. doi:10.1002/path.4431 |
| 23 | 饶东平, 傅美芹, 陈英杰, 等. 广东省江门市鼻咽癌筛查人群EB病毒感染与流行现状[J]. 中国热带医学, 2021,21(6):567-570. |
| 24 | 黄雪珍, 陈光辉, 莫和国, 等. 广东中山小榄地区大样本人群鼻咽癌筛查两种抗体水平分析[J]. 中国医学创新, 2014,11(22):89-91. doi:10.3969/j.issn.1674-4985.2014.22.032 |
| 25 | 江旭, 夏巍, 李学华, 等. 广西五地区25万自然人群EB病毒VCA-IgA联合EBNA1-IgA鼻咽癌筛查结果分析[J]. 中华肿瘤防治杂志, 2021,28(2):100-105. |
| 26 | 吴晶, 辛颖, 陈云燕, 等. 北京地区EBV抗体水平及阳性率调查[J]. 国际检验医学杂志, 2023,44(7):866-870. doi:10.3969/j.issn.1673-4130.2023.07.019 |
| 27 | 张晗, 张超彦, 谢秋霞, 等. 北京市体检人群EB病毒联合抗体检测结果分析[J]. 检验医学, 2020,35(3):247-250. |
| 28 | 刘杰, 王利娟, 谷愉愉, 等. 体检人群EB病毒感染情况分析[J]. 国际检验医学杂志, 2020,41(10):1158-1160. doi:10.3969/j.issn.1673-4130.2020.10.002 |
| 29 | 冯婉君. 玉溪市成年人糖尿病流行现状及其危险因素研究[D]. 大理:大理大学, 2023. |
| 30 | 周莉, 张斌, 杨柳叶, 等. 煤矿工人高血压患病情况及影响因素分析[J]. 实用医学杂志, 2020,36(22):3144-3148. doi:10.3969/j.issn.1006-5725.2020.22.023 |
| 31 | FAUSTMAN D L. EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop?[J]. Expert Rev Clin Immunol, 2013,9(2):95-97. doi:10.1586/eci.12.101 |
| 32 | 丘雅维, 许小超, 张曼, 等. 糖尿病与鼻咽癌相关性的临床调查与分析[J]. 中山大学学报, 2009,30(S2):211-214. |
| 33 | 任亚璇. 长春市老年人群高血压现况调查及miR-3656/TFAP2C/KLF10轴介导血管内皮功能障碍的作用机制研究[D]. 长春:吉林大学, 2023. |
/
| 〈 |
|
〉 |